| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023238137 |
| P356 | DOI | 10.1007/BF01218443 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/BF01218443/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/BF01218443 | ||
| http://link.springer.com/content/pdf/10.1007/BF01218443.pdf | ||
| P698 | PubMed publication ID | 4772979 |
| P2093 | author name string | G. Zahnd | |
| J. Fabre | |||
| L. Balant | |||
| R. Schwarz | |||
| A. Gorgia | |||
| P2860 | cites work | Carbohydrate metabolism in uremia: blood glucose response to sulfonylurea | Q72305471 |
| Solid-Phase Radioimmunoassay in Antibody-Coated Tubes | Q72314401 | ||
| [An automatic micro-method for the quantitative analysis of aldohexoses in biological fluids by o-toluidine] | Q76413803 | ||
| DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE | Q76574783 | ||
| A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas | Q78584904 | ||
| A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter | Q114837163 | ||
| Pharmacokinetic aspects of drug metabolism | Q40000582 | ||
| Immunoassay of insulin with insulin-antibody precipitate | Q42961363 | ||
| The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy | Q70355190 | ||
| Pharmacokinetics and metabolism of N-(4-( -(5-methylpyrazine-2-carboxyamido)-ethyl)-benzensulfonyl)-N'cyclohexylurea (K 4024) in experimental animals and in man | Q70415081 | ||
| [Metabolism of HB 419 in animals] | Q71356391 | ||
| [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man] | Q71356411 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| internal medicine | Q11180 | ||
| P304 | page(s) | 331-338 | |
| P577 | publication date | 1973-09-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Pharmacokinetics of glipizide in man: influence of renal insufficiency | |
| Pharmacokinetics of glipizide in man: Influence of renal insufficiency |
| Q46970225 | Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers |
| Q40307292 | Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs |
| Q34714607 | Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. |
| Q34728399 | Comparison of the pharmacokinetics of glipizide and glibenclamide in man |
| Q91638345 | Diabetes Management in Older Adults With Chronic Kidney Disease |
| Q38541323 | Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors |
| Q27012546 | Diabetic kidney disease: a report from an ADA Consensus Conference |
| Q90429607 | Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patient |
| Q36911708 | Diabetic nephropathy in the elderly. |
| Q66706024 | Diazoxide, glipizide, hypertension and hypoglycaemia |
| Q39946671 | Drug Selection and Dosage in Renal Insufficiency |
| Q40874614 | Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients |
| Q71160573 | Electron-capture gas chromatography of plasma sulphonylureas after extractive methylation |
| Q40898248 | Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study |
| Q54467706 | Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden) |
| Q34693555 | Glipizide: a review of its pharmacological properties and therapeutic use. |
| Q33792375 | Management of diabetes mellitus in patients with chronic kidney disease |
| Q38193694 | Metformin and other antidiabetic agents in renal failure patients |
| Q38631248 | Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update |
| Q41149331 | Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency |
| Q73487086 | Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease |
| Q71040526 | Radioimmunoassay of glipizide in human plasma |
| Q35372914 | Renal Failure, Drug Pharmacokinetics and Drug Action |
| Q39662366 | The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs |
Search more.